Zimmer Biomet closes acquisition of Monogram Technologies

Zimmer Biomet closes acquisition of Monogram Technologies
Zimmer Biomet to buy Monogram for $177M in cash
Zimmer Biomet to buy OrthoGrid Systems
Zimmer Biomet to acquire soft tissue healing company Embody
19.2BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US98956P1021
CUSIP
98956P102
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
25.53
PEG Ratio
2.17
Book Value
66.89
Dividend Share
0.96
Dividend Yield
0.95%
Earnings Share
3.96
Wall Street Target Price
117.48
EPS Estimate Current Year
8.55
EPS Estimate Next Year
8.96
EPS Estimate Current Quarter
1.8814
EPS Estimate Next Quarter
2.4931
Most Recent Quarter
-
Revenue TTM
8,570,399,744
Gross Profit TTM
5,942,099,968
EBITDA
2,541,299,968
Profit Margin
8.95%
Return On Assets TTM
3.81%
Return On Equity TTM
6.03%
Revenue Per Share TTM
44.24
Qtly Revenue Growth YOY
3.10%
Diluted Eps TTM
3.96
Qtly Earnings Growth YOY
-13.80%
Trailing PE
25.53
Forward PE
11
Price Sales TTM
2.2325
Price Book MRQ
1.5102
Enterprise Value Revenue
3
Enterprise Value EBITDA
11
46.87
-3.03%23.29
-2.56%42.10
-2.43%28.61
-2.42%101.98
-2.07%80.84
-1.51%79.41
-1.30%309.53
-1.30%103.50
-0.81%100.15
-0.55%